Opinion Article - Insights in Nutrition and Metabolism (2023) Volume 7, Issue 5
Exploring the impact of epigenetic parameters in obesity.
Department of Medicine, Sao Paulo State University, Botucatu, Brazil
- *Corresponding Author:
- Gracia Fabia
Department of Medicine
Sao Paulo State University
Received:24-Aug-2023,Manuscript No. AAINM-23-112843; Editor assigned: 28-Aug-2023, PreQC No. AAINM-23-112843(PQ); Reviewed:11-Sept-2023, QC No. AAINM-23-112843; Revised:16-Sept-2023, Manuscript No. AAINM-23-112843(R); Published:22-Sept-2023, DOI: 10.35841/aainm- 7.5.161
Citation: Fabia G. Exploring the impact of epigenetic parameters in obesity. Insights Nutr Metab. 2023;7(4):161
Obesity is a global epidemic, with its prevalence steadily increasing over the past few decades. While factors such as diet and physical activity play a significant role in obesity, it is increasingly evident that genetics alone cannot explain the obesity epidemic. Epigenetics, the study of heritable changes in gene expression that do not involve alterations to the DNA sequence itself, has emerged as a crucial player in understanding the complex nature of obesity. In this article, we will delve into the role of epigenetic factors in obesity, exploring how they can influence an individual's susceptibility to weight gain and the development of obesity-related health issues. Epigenetic modifications are reversible chemical changes to DNA and associated proteins that regulate gene expression without altering the underlying DNA sequence. These modifications include DNA methylation, histone modifications, and non-coding RNA molecules. Epigenetic changes can be influenced by a variety of environmental factors, including diet, stress, toxins, and more.
One of the most extensively studied epigenetic modifications in the context of obesity is DNA methylation. DNA methylation involves the addition of a methyl group (-CH3) to cytosine residues in the DNA molecule. When DNA is heavily methylated in specific regions, it often leads to gene silencing, preventing the associated genes from being expressed. Conversely, reduced methylation can enhance gene expression.
Epigenetic modifications and fat storage genes: Several genes associated with fat storage and metabolism have been found to undergo significant DNA methylation changes in individuals with obesity. For example, the promoter regions of genes involved in adipogenesis (the formation of fat cells) and lipid metabolism are often hypermethylated in obese individuals. This hypermethylation can lead to reduced gene expression, ultimately contributing to an increased tendency for fat storage.
Fetal programming and obesity risk: Epigenetic modifications can also occur early in life, affecting an individual's long-term risk of obesity. The concept of "fetal programming" suggests that environmental factors experienced in utero can lead to lasting epigenetic changes that predispose individuals to obesity later in life. Maternal nutrition, stress, and other factors during pregnancy can influence the epigenetic marks on genes related to metabolism and appetite regulation in the developing fetus.
Histones are proteins that help package DNA into a compact structure called chromatin. Chemical modifications to histone proteins can alter the accessibility of DNA to the cellular machinery responsible for gene expression. Histone modifications include acetylation, methylation, phosphorylation, and more.
Histone acetylation and obesity: Histone acetylation typically results in an open chromatin structure, allowing for increased gene expression. In the context of obesity, alterations in histone acetylation patterns have been linked to changes in the expression of genes associated with energy balance and metabolism. For instance, the histone acetylation status of genes involved in appetite regulation and insulin sensitivity can impact an individual's susceptibility to obesity.
Transgenerational effects: Histone modifications, like DNA methylation, can also be passed down through generations, potentially affecting the obesity risk of offspring. Studies in animals have shown that obesity-induced changes in histone modifications can be inherited by the next generation, suggesting a transgenerational epigenetic influence on obesity susceptibility.
Non-coding RNAs (ncRNAs) are RNA molecules that do not encode proteins but play essential roles in gene regulation. Two types of ncRNAs, microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), have gained attention for their involvement in obesity.
miRNAs and Obesity: MiRNAs are small RNA molecules that can bind to messenger RNAs (mRNAs) and inhibit their translation into proteins. Several miRNAs have been identified as regulators of genes associated with obesity, including those involved in adipogenesis, lipid metabolism, and appetite regulation. Dysregulation of miRNA expression has been observed in obese individuals and may contribute to the development of obesity-related complications.
lncRNAs and Metabolic Regulation: Long non-coding RNAs are involved in diverse cellular processes, including metabolic regulation. Some lncRNAs have been implicated in the control of adipogenesis and insulin sensitivity. Their dysregulation can disrupt metabolic homeostasis and promote obesity.
Epigenetic factors and obesity-related health issues
The influence of epigenetic factors in obesity extends beyond just weight gain. These factors can also impact various health issues associated with obesity, such as type 2 diabetes, cardiovascular disease, and metabolic syndrome.
Type 2 diabetes: Epigenetic modifications can affect insulin sensitivity and glucose metabolism. For instance, changes in DNA methylation and histone acetylation in genes involved in insulin signaling pathways can lead to insulin resistance, a hallmark of type-2 diabetes. Understanding these epigenetic mechanisms may provide insights into novel therapeutic targets for diabetes management.
Cardiovascular disease: Obesity is a significant risk factor for cardiovascular disease. Epigenetic alterations in genes related to lipid metabolism, blood pressure regulation, and inflammation can contribute to the development of atherosclerosis and other cardiovascular complications in obese individuals.
Metabolic syndrome: Metabolic syndrome is a cluster of conditions, including abdominal obesity, high blood pressure, elevated blood sugar, and abnormal lipid profiles, that increase the risk of heart disease and type 2 diabetes. Epigenetic factors can contribute to the development and progression of metabolic syndrome by influencing genes involved in these metabolic processes.
Obesity is a multifaceted health issue influenced by a complex interplay of genetic, environmental, and epigenetic factors. Epigenetic modifications, including DNA methylation, histone modifications, and non-coding RNAs, play crucial roles in regulating gene expression related to metabolism, appetite regulation, and fat storage. These epigenetic changes can be influenced by various environmental factors, including diet, stress, and maternal health during pregnancy. Moreover, they can have transgenerational effects, impacting the obesity risk of future generations. The epigenetic basis of obesity provides valuable insights into its development and progression. It also opens new avenues for potential therapeutic interventions. While much progress has been made in elucidating the epigenetic factors involved in obesity, ongoing research is needed to uncover the full extent of their influence and to develop targeted treatments that can mitigate the obesity epidemic and its associated health issues.
- McKay JA, Mathers JC.Diet induced epigenetic changes and their implications for health.Acta Physiol. 2011;202(2):103-18.
- Boissonnas CC, Abdalaoui HE, Haelewyn V, et al.Specific epigenetic alterations of IGF2-H19 locus in spermatozoa from infertile men.Eur J Hum Genet. 2010;18(1):73-80.
- Kerjean A, Dupont JM, Vasseur C, et al.Establishment of the paternal methylation imprint of the human H19 and MEST/PEG1 genes during spermatogenesis.Hum Mol Genet. 2000;9(14):2183-7.
- Ravelli GP, Stein ZA, Susser MW.Obesity in young men after famine exposure in utero and early infancy.N Eng J Med. 1976;295(7):349-53.
- Painter RC, De Rooij SR, Bossuyt PM, et al.A possible link between prenatal exposure to famine and breast cancer: A preliminary study.Am J Hum Biol. 2006;18(6):853-6.